About this item
Product details
For treatment of Eczema Eczemus (Tacrolimus) is a macrolide immunosuppressant produced by streptomyces tsukubaensis. It has been demonstrated that Eczemus (Tacrolimus) inhibits T-lymphocyte activation by first binding to an intracellular protein,FKBP-12. Eczemus (Tacrolimus) has also been shown to inhibit the release of inflammatory mediators from skin mast cells, basophils and eosinophils. Eczemus (Tacrolimus) ointment does not affect collagen synthesis in humans. Indications Eczemus (Tacrolimus) 0.03% Ointment is indicated for short-term and intermittent long-term therapy in the treatment of moderate to severe atopic dermatitis (eczema) in children. Composition 10g ointment contains: Tacrolimus (as monohydrate): 0.3 mg Directions for Use Apply Eczemus (Tacrolimus) Ointment twice a day, about 12 hours apart.
- Medicines
- 10 g
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Brookes Pharma
- SKU
- 8961101530310
- Variant
- 10 g
- Tags
- Eczema, Medicine
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
